Skip to main content

Advertisement

Log in

Racial, Ethnic, and Socioeconomic Differences in Primary Care No-Show Risk with Telemedicine During the COVID-19 Pandemic

  • Original Research
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

Abstract

Background

The coronavirus 2019 (COVID-19) pandemic resulted in rapid implementation of telemedicine. Little is known about the impact of telemedicine on both no-show rates and healthcare disparities on the general primary care population during the pandemic.

Objective

To compare no-show rates between telemedicine and office visits in the primary care setting, while controlling for the burden of COVID-19 cases, with focus on underserved populations.

Design

Retrospective cohort study.

Setting

Multi-center urban network of primary care clinics between April 2021 and December 2021.

Participants

A total of 311,517 completed primary care physician visits across 164,647 patients.

Main Measures

The primary outcome was risk ratio of no-show incidences (i.e., no-show rates) between telemedicine and office visits across demographic sub-groups including age, ethnicity, race, and payor type.

Results

Compared to in-office visits, the overall risk of no-showing favored telemedicine, adjusted risk ratio of 0.68 (95% CI 0.65 to 0.71), absolute risk reduction (ARR) 4.0%. This favorability was most profound in several cohorts with racial/ethnic and socioeconomic differences with risk ratios in Black/African American 0.47 (95% CI 0.41 to 0.53), ARR 9.0%; Hispanic/Latino 0.63 (95% CI 0.58 to 0.68), ARR 4.6%; Medicaid 0.58 (95% CI 0.54 to 0.62) ARR 7.3%; Self-Pay 0.64 (95% CI 0.58 to 0.70) ARR 11.3%.

Limitation

The analysis was limited to physician-only visits in a single setting and did not examine the reasons for visits.

Conclusion

As compared to office visits, patients using telemedicine have a lower risk of no-showing to primary care appointments. This is one step towards improved access to care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. CDC Covid Data tracker [Internet]. Centers for Disease Control and Prevention. Centers for Disease Control and Prevention. Available at: https://covid.cdc.gov/covid-data-tracker. Accessed 10 Jul 2022.

  2. Andraska EA, Alabi O, Dorsey C, et al. Health care disparities during the COVID-19 pandemic. Semin Vasc Surg. 2021;34(3):82–8.

  3. Thebault R, Tran AB, Williams V. The coronavirus is infecting and killing Black Americans at an alarmingly high rate [Internet]. The Washington Post. WP Company; 2020. Available at: https://www.washingtonpost.com/nation/2020/04/07/coronavirus-is-infecting-killing-black-americans-an-alarmingly-high-rate-post-analysis-shows/. Accessed 10 Jul 2022.

  4. Riley WJ. Health disparities: gaps in access, quality and affordability of medical care. Trans Am Clin Climatol Assoc. 2012;123:167-174.

  5. LaVeist TA, Gaskin D, Richard P. Estimating the economic burden of Racial Health Inequalities in the United States. Int J Health Serv. 2011;41(2):231–8.

  6. Bove AA, Homko CJ, Santamore WP, et al. Managing hypertension in urban underserved subjects using telemedicine—a clinical trial. Am Heart J. 2013;165(4):615–21.

  7. Battineni G, Nittari G, Sirignano A, et al. Are telemedicine systems effective healthcare solutions during the COVID-19 pandemic? J Taibah Univ Med Sci. 2021;16(3):305-306.

  8. Bynum AB, Irwin CA, Cranford CO et al. The impact of telemedicine on patients' cost savings: Some preliminary findings. Telemed J e-Health. 2003;9(4):361–7.

  9. Telemedicine [Internet]. Medicaid. Available at: https://www.medicaid.gov/medicaid/benefits/telemedicine/index.html. Accessed 10 Jul 2022.

  10. Koonin LM, Hoots B, Tsang CA, et al. Trends in the use of telehealth during the emergence of the COVID-19 pandemic — United States, January–March 2020. MMWR Morb Mortal Wkly Rep. 2020;69(43):1595–9.

  11. Huang J, Gopalan A, Muelly E, et al. Primary care video and telephone telemedicine during the COVID-19 pandemic: treatment and follow-up health care utilization. Am J Manag Care. 2023;29(1):e13-e17. Published 2023 Jan 1.

  12. Scott Kruse C, Karem P, Shifflett K, et al. Evaluating barriers to adopting telemedicine worldwide: A systematic review. J Telemed Telecare. 2016;24(1):4–12.

  13. Hjelm NM. Benefits and drawbacks of telemedicine. J Telemed Telecare. 2005;11(2):60–70.

  14. Vogels EA. Digital divide persists even as Americans with lower incomes make gains in tech adoption [Internet]. Pew Research Center. Pew Research Center; 2021. Available at: https://www.pewresearch.org/fact-tank/2021/06/22/digital-divide-persists-even-as-americans-with-lower-incomes-make-gains-in-tech-adoption/. Accessed 10 Jul 2022.

  15. Segrelles-Calvo G, López-Padilla D, de Granda-Orive JI. Pros and cons of telemedicine in the management of patients with chronic respiratory diseases. Arch Bronconeumol (English Edition). 2016;52(12):575–6.

  16. Moghaddamjou A, Salaheen Z, Fehlings MG. A New Era of Practice: COVID 19 and Neurosurgical Care via Telemedicine [Internet]. AANS Neurosurgeon. 2021. Available at: https://www.aansneurosurgeon.org/feature/a-new-era-of-practice-covid-19-and-neurosurgical-care-via-telemedicine/. Accessed 10 Jul 2022.

  17. Mira-Solves JJ, Orozco-Beltrán D, Sánchez-Molla M, et al. Evaluation of satisfaction with telemedicine devices and with the results of the care received among chronic patients. Aten Primaria. 2014;46:16–23.

  18. Daniel H, Sulmasy LS; Health and Public Policy Committee of the American College of Physicians. Policy recommendations to guide the use of telemedicine in primary care settings: an American College of Physicians position paper. Ann Intern Med. 2015;163(10):787–9.

  19. Baker J, Stanley A. Telemedicine Technology: A review of services, equipment, and other aspects. Curr Allergy Asthma Rep. 2018;18(11).

  20. Burke BL Jr, Hall RW; Section on Telehealth Care. Telemedicine: Pediatric Applications. Pediatrics. 2015;136(1):e293-e308.

  21. Chou EY, Moore K, Zhao Y, et al. Neighborhood effects on missed appointments in a large urban academic multispecialty practice. J Gen Intern Med. 2021;37(4):785–92.

  22. Kaplan-Lewis E, Percac-Lima S. No-show to primary care appointments. J Prim Care Commun Health. 2013;4(4):251–5.

  23. No show appointments: Why they happen and how to reduce them - MGMA [Internet]. Available at: https://www.mgma.com/getattachment/Resources/Resources/Business-Strategy/No-Show-Appointments-Why-They-Happen-and-How-to-R/No-Show-Appointment-Paper.pdf.aspx?lang=en-US&ext=.pdf. Accessed 10 Jul 2022.

  24. Zhang D, Shi L, Han X, et al. Disparities in telehealth utilization during the COVID-19 pandemic: Findings from a nationally representative survey in the United States [published online ahead of print, 2021 Oct 11]. J Telemed Telecare. 2021;1357633X211051677.

  25. Fuerst ML. Black & Hispanic patients used telehealth less during pandemic. Oncology Times. 2021;43(1):35–.

  26. Wray CM, Tang J, Shah S, et al. Sociodemographics, Social Vulnerabilities, and Health Factors Associated with Telemedicine Unreadiness Among US Adults. J Gen Intern Med. 2022;37:1811–1813.

  27. Drerup B, Espenschied J, Wiedemer J, et al. Reduced no-show rates and sustained patient satisfaction of telehealth during the COVID-19 pandemic. Telemed e-Health. 2021;27(12):1409–15.

  28. Darrat I, Tam S, Boulis M, et al. Socioeconomic disparities in patient use of telehealth during the coronavirus disease 2019 surge. JAMA Otolaryngol Head Neck Surg. 2021;147(3):287.

  29. Alkilany R, Tarabichi Y, Hong R. Telemedicine visits during covid ‐19 improved clinic show rates. ACR Open Rheumatol. 2021;4(2):136–41.

  30. Kemp MT, Liesman DR, Brown CS, et al. Factors associated with increased risk of patient no-show in telehealth and traditional surgery clinics. J Am Coll Surg. 2020;231(6):695–702.

  31. Mafi JN, Craff M, Vangala S, et al. Trends in US ambulatory care patterns during the COVID-19 pandemic, 2019-2021. JAMA. 2022;327(3):237.

  32. Zou G. A modified Poisson regression approach to prospective studies with Binary Data. American J Epidemiol. 2004;159(7):702–6.

  33. Branson S. Telehealth: Improving care of chronic conditions [Internet]. Assisted Home Health and Hospice. Available at: https://assistedcares.com/telehealth-improving-care-of-chronic-conditions/. Accessed 10 Jul 2022.

  34. Witten B. [Internet]. Home Dialysis Central. Available at: https://homedialysis.org/news-and-research/blog/288telehealth-for-home-dialysis. Accessed 10 Jul 2022.

  35. Hsiao V, Chandereng T, Lankton RL, et al. Disparities in telemedicine access: A cross-sectional study of a newly established infrastructure during the COVID-19 pandemic. Appl Clin Inform. 2021;12(03):445–58.

  36. Rodriguez JA, Betancourt JR, Sequist TD, et al. Differences in the use of telephone and video telemedicine visits during the COVID-19 pandemic. Am J Manag Care. 2021 Jan;27(1):21-26.

  37. Alishahi ML, Sevick C, Mathieu S, Everhart R, Gritz M. No-Show Rates for Telemedicine Versus In-Person Appointments During the COVID-19 Pandemic: Implications for Medicaid Populations. J Ambul Care Manage. 2022;45(4):332-340.

  38. Meno M, Abe J, Fukui J, et al. Telehealth amid the covid-19 pandemic: Perception among Asian, Native Hawaiian and pacific islander cancer patients. Future Oncol. 2021;17(23):3077–85.

  39. Johnson PJ, Ghildayal N, Ward AC, et al. Disparities in potentially avoidable emergency department (ED) care. Med Care. 2012;50(12):1020–8.

  40. Kontos E, Blake KD, Chou WY, Prestin A. Predictors of eHealth usage: insights on the digital divide from the Health Information National Trends Survey 2012. J Med Internet Res. 2014;16(7):e172.

  41. Anthony DL, Campos-Castillo C, Lim PS. Who isn’t using patient portals and why? evidence and implications from a national sample of US adults. Health Affairs. 2018;37(12):1948–54.

  42. Nouri S, Khoong EC, Lyles CR, et al. Addressing equity in telemedicine for chronic disease management during the Covid-19 pandemic. NEJM Catal. 2020;1(3):1-13.

  43. Siow MY, Walker JT, Britt E, et al. What Was the Change in Telehealth Usage and Proportion of No-show Visits for an Orthopaedic Trauma Clinic During the COVID-19 Pandemic?. Clin Orthop Relat Res. 2020;478(10):2257-2263.

  44. Eberly LA, Khatana SA, Nathan AS, et al. Telemedicine outpatient cardiovascular care during the COVID-19 pandemic. Circulation. 2020;142(5):510–2.

  45. Campos-Castillo C, Anthony D. Racial and ethnic differences in self-reported telehealth use during the COVID-19 pandemic: A secondary analysis of a US survey of internet users from late March. J Am Med Inform Assoc. 2020;28(1):119–25.

  46. Shah DA, Sall D, Peng W, Sharer R, Essary AC, Radhakrishnan P. Exploring the role of telehealth in providing equitable healthcare to the vulnerable patient population during COVID-19 [published online ahead of print, 2022 Jul 14]. J Telemed Telecare. 2022;1357633X221113711.

  47. Pierce RP, Stevermer JJ. Disparities in the use of telehealth at the onset of the COVID-19 public health emergency. J Telemed Telecare. 2023;29(1):3-9.

  48. Ray KN, Chari AV, Engberg J, et al. Opportunity costs of ambulatory medical care in the United States. Am J Manag Care. 2015;21(8):567-574.

  49. Drake C, Lian T, Cameron B, et al. Understanding telemedicine's “New normal”: Variations in telemedicine use by Specialty Line and patient demographics. Telemed e-Health. 2022;28(1):51–9.

  50. Frydman JL, Li W, Gelfman LP, et al. Telemedicine Uptake Among Older Adults During the COVID-19 Pandemic. Ann Intern Med. 2022;175(1):145-148.

  51. Roberts ET, Mehrotra A. Assessment of disparities in digital access among Medicare beneficiaries and implications for telemedicine. JAMA Intern Med. 2020;180(10):1386.

  52. Albritton J, Ortiz A, Wines R, et al. Video Teleconferencing for Disease Prevention, Diagnosis, and Treatment : A Rapid Review. Ann Intern Med. 2022;175(2):256-266.

  53. Telehealth interventions to improve chronic disease [Internet]. Centers for Disease Control and Prevention. Centers for Disease Control and Prevention; 2020. Available at: https://www.cdc.gov/dhdsp/pubs/telehealth.htm. Accessed 10 Jul 2022.

  54. Reed ME, Huang J, Parikh R, et al. Patient-Provider Video Telemedicine Integrated With Clinical Care: Patient Experiences. Ann Intern Med. 2019;171(3):222-224.

  55. Reed ME, Huang J, Graetz I, et al. Patient Characteristics Associated With Choosing a Telemedicine Visit vs Office Visit With the Same Primary Care Clinicians. JAMA Netw Open. 2020;3(6):e205873.

  56. Goodrich K. How the CARES Act supports America’s Healthcare System in the Fight against COVID 19. JW News; 2020. Available at: https://www.jdsupra.com/legalnews/how-the-cares-act-supports-america-s-59894/. Accessed 28 Jul 2022.

  57. Medicare and Medicaid policies. Telehealth.hhs.gov;2021. Available at: https://telehealth.hhs.gov/providers/telehealth-policy/medicare-and-medicaid-policies. Accessed 28 Jul 2022.

Download references

Funding

This work was supported by the Federation of State Medical Boards (FSMB).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dania A. Shah MD.

Ethics declarations

Conflict of Interest:

Consultancies: Dr Curt Bay received a consulting fee to assist in data analysis.

Advisory Board: Dr Alethea Turner received payment for her participation on the editorial board for the Association of Family Medicine Residency Directors (AFMRD) and Family Medicine Residency Curriculum Resource as an associate editor. Drs Alethea Turner and Dmitry Bisk received payment as the members of Innovation Care partners (ICP) and Clinical Integration Committee (CIC).

Leadership/Fiduciary role: Dr Priya Radhakrishnan is the Governor of the Arizona Chapter of the American College of Physicians (ACP). She is also the Chair Elect of the ACP Board of Governors and Principal Investigator of the Improving Health Equity via Telemedicine (IHET) grant. Dr Radhakrishnan did not receive any payment.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Dania A. Shah, MD, and Rustan Sharer, MD, are co-first authors.

Supplementary Information

Below is the link to the electronic supplementary material.

ESM 1

(DOCX 744 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shah, D.A., Sharer, R., Sall, D. et al. Racial, Ethnic, and Socioeconomic Differences in Primary Care No-Show Risk with Telemedicine During the COVID-19 Pandemic. J GEN INTERN MED 38, 2734–2741 (2023). https://doi.org/10.1007/s11606-023-08236-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11606-023-08236-x

Navigation